Al Farsi A - Search Results

1

Awareness, understanding, attitude and barriers toward prescribing modern cancer immunotherapies in the Arabian Gulf countries.

Al-Shamsi HO, Tashkandi E, Bukhari N, Al Farsi A, Alnajjar A, Alhuraiji A, Foheidi M, Sagheir A, Bin Thani K, Al Bahrani B, Alrawi S. Al-Shamsi HO, et al. Among authors: al bahrani b, al farsi a. Gulf J Oncolog. 2018 May;1(27):45-51. Gulf J Oncolog. 2018. PMID: 30145551

2

Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.

Al-Shamsi HO, Al Farsi A, Ellis PM. Al-Shamsi HO, et al. Among authors: al farsi a. Clin Lung Cancer. 2014 Jul;15(4):274-80. doi: 10.1016/j.cllc.2014.02.003. Epub 2014 Feb 19. Clin Lung Cancer. 2014. PMID: 24685356

3

COVID-19 amongst cancer patients: An experience from Oman.

Al Bahrani BJ, Mehdi I, Khamis FA, Al Farsi AM, Fahdi FA, Al Lawati NA. Al Bahrani BJ, et al. J Pak Med Assoc. 2021 Nov;71(11):2563-2570. doi: 10.47391/JPMA.11915. J Pak Med Assoc. 2021. PMID: 34783738 Free article.

4

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC).

Venniyoor A, Al Farsi AA, Al Bahrani B. Venniyoor A, et al. Among authors: al bahrani b, al farsi aa. Cureus. 2021 Aug 20;13(8):e17320. doi: 10.7759/cureus.17320. eCollection 2021 Aug. Cureus. 2021. PMID: 34557366 Free PMC article. Review.

5

Thrombotic events in metastatic colorectal cancer patients treated with leucovorin, fluorouracil and irinotican (FOLFIRI) plus bevacizumab.

Al-Shamsi HO, Al Farsi A, Anjum M, Shen H, Zbuk K, Cook RJ, Linkins LA, Major P. Al-Shamsi HO, et al. Among authors: al farsi a. J Gastrointest Oncol. 2015 Jun;6(3):274-9. doi: 10.3978/j.issn.2078-6891.2015.025. J Gastrointest Oncol. 2015. PMID: 26029454 Free PMC article.

6

Impact of Screening Programs on Stage Migration in Breast Cancer.

Jaffar Al Bahrani B, Mehdi I, Al Lawati TM, Al Farsi AM, Al Lawati NA, Al Harthi H. Jaffar Al Bahrani B, et al. Among authors: al farsi am. Gulf J Oncolog. 2022 Jan;1(38):38-46. Gulf J Oncolog. 2022. PMID: 35156643

7

Association of E-cadherin (CDH1) gene polymorphisms and gastric cancer risk.

Al-Moundhri MS, Al-Khanbashi M, Al-Kindi M, Al-Nabhani M, Burney IA, Al-Farsi A, Al-Bahrani B. Al-Moundhri MS, et al. Among authors: al kindi m, al nabhani m, al bahrani b, al khanbashi m, al farsi a. World J Gastroenterol. 2010 Jul 21;16(27):3432-6. doi: 10.3748/wjg.v16.i27.3432. World J Gastroenterol. 2010. PMID: 20632448 Free PMC article.

8

Management guidelines for stage III non-small cell lung cancer.

Jazieh AR, Zeitouni M, Alghamdi M, Alrujaib M, Lotfi S, Abu Daff S, Alomair A, Alshehri S, Alhusaini H, Allehebi A, Ansari J, Alnassar M, Jafar H, Alfarsi A, Abdelhafeez N, Alkattan K. Jazieh AR, et al. Crit Rev Oncol Hematol. 2021 Jan;157:103144. doi: 10.1016/j.critrevonc.2020.103144. Epub 2020 Nov 7. Crit Rev Oncol Hematol. 2021. PMID: 33254035 Review.

9

Treatment paradigms for patients with metastatic non-small cell lung cancer, squamous lung cancer: first, second, and third-line.

Al-Farsi A, Ellis PM. Al-Farsi A, et al. Front Oncol. 2014 Jun 27;4:157. doi: 10.3389/fonc.2014.00157. eCollection 2014. Front Oncol. 2014. PMID: 25019058 Free PMC article. Review.

10

Anti-angiogenic therapy in advanced non-small cell lung carcinoma (NSCLC): is there a role in subsequent lines of therapy?

Al Farsi A, Ellis PM. Al Farsi A, et al. J Thorac Dis. 2015 Mar;7(3):214-6. doi: 10.3978/j.issn.2072-1439.2015.01.41. J Thorac Dis. 2015. PMID: 25922692 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page